Search research articles
Contact Us
Filters
Showing results (41-50 of 84) with videos related to
Page
of 9
Sort By:
Current Medical Research and Opinion
|
October 30, 2020
Economic burden of treatment-resistant depression in privately insured US patients with co-occurring anxiety disorder and/or substance use disorder
Maryia Zhdanava, Harsh Kuvadia, Kruti Joshi, et al.
Journal of Managed Care & Specialty Pharmacy
|
June 20, 2020
Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions
Maryia Zhdanava, Harsh Kuvadia, Kruti Joshi, et al.
BMC Health Services Research
|
August 26, 2004
Encouraging physician appropriate prescribing of non-steroidal anti-inflammatory therapies: protocol of a randomized controlled trial [ISRCTN43532635]
Malcolm Doupe, Alan Katz, Brent Kvern, et al.
BMC Pulmonary Medicine
|
May 14, 2026
Real-world treatment and healthcare resource utilization patterns among patients with advanced non-small cell lung cancer treated with amivantamab: a retrospective study using insurance claims data
David Waterhouse, Iris Lin, Laura Morrison, et al.
Plos One
|
April 15, 2016
Evaluation of CT Perfusion Biomarkers of Tumor Hypoxia
Qi Qi, Timothy Pok Chi Yeung, Ting-Yim Lee, et al.
Age and Ageing
|
May 15, 2018
Effectiveness of a multifaceted intervention to reduce night-time sedative use in a rehabilitation unit: a pre-post intervention study
Juliana Delos Reyes, Anthony T Sharkey, Laura Morrison, et al.
Journal of Affective Disorders
|
May 21, 2022
Excess healthcare resource utilization and healthcare costs among privately and publicly insured patients with major depressive disorder and acute suicidal ideation or behavior in the United States
Maryia Zhdanava, Jennifer Voelker, Dominic Pilon, et al.
International Journal of Environmental Research and Public Health
|
March 28, 2024
Frailty in an Adult Acute Hospital Population: Predictors, Prevalence, and Outcomes
Rónán O'Caoimh, Laura Morrison, Maria Costello, et al.
Journal of Medical Economics
|
January 11, 2024
Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation
Deborah R Kaye, Ibrahim Khilfeh, Erik Muser, et al.
Advances in Therapy
|
August 9, 2021
Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug-Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant Depression
Maryia Zhdanava, Swapna Karkare, Dominic Pilon, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 84) with videos related to
Sort By:
Page
of 9
Current Medical Research and Opinion
|
October 30, 2020
Economic burden of treatment-resistant depression in privately insured US patients with co-occurring anxiety disorder and/or substance use disorder
Maryia Zhdanava, Harsh Kuvadia, Kruti Joshi, et al.
Journal of Managed Care & Specialty Pharmacy
|
June 20, 2020
Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions
Maryia Zhdanava, Harsh Kuvadia, Kruti Joshi, et al.
BMC Health Services Research
|
August 26, 2004
Encouraging physician appropriate prescribing of non-steroidal anti-inflammatory therapies: protocol of a randomized controlled trial [ISRCTN43532635]
Malcolm Doupe, Alan Katz, Brent Kvern, et al.
BMC Pulmonary Medicine
|
May 14, 2026
Real-world treatment and healthcare resource utilization patterns among patients with advanced non-small cell lung cancer treated with amivantamab: a retrospective study using insurance claims data
David Waterhouse, Iris Lin, Laura Morrison, et al.
Plos One
|
April 15, 2016
Evaluation of CT Perfusion Biomarkers of Tumor Hypoxia
Qi Qi, Timothy Pok Chi Yeung, Ting-Yim Lee, et al.
Age and Ageing
|
May 15, 2018
Effectiveness of a multifaceted intervention to reduce night-time sedative use in a rehabilitation unit: a pre-post intervention study
Juliana Delos Reyes, Anthony T Sharkey, Laura Morrison, et al.
Journal of Affective Disorders
|
May 21, 2022
Excess healthcare resource utilization and healthcare costs among privately and publicly insured patients with major depressive disorder and acute suicidal ideation or behavior in the United States
Maryia Zhdanava, Jennifer Voelker, Dominic Pilon, et al.
International Journal of Environmental Research and Public Health
|
March 28, 2024
Frailty in an Adult Acute Hospital Population: Predictors, Prevalence, and Outcomes
Rónán O'Caoimh, Laura Morrison, Maria Costello, et al.
Journal of Medical Economics
|
January 11, 2024
Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation
Deborah R Kaye, Ibrahim Khilfeh, Erik Muser, et al.
Advances in Therapy
|
August 9, 2021
Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug-Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant Depression
Maryia Zhdanava, Swapna Karkare, Dominic Pilon, et al.
Page
of 9